System Maintenance Alert

Our website will be undergoing planned maintenance on May 29, 2024, at 8:30 PM ET. During this time, the site will be temporarily unavailable. We apologize for any inconvenience this may cause and appreciate your understanding.

Recognizing Risk and Benefits of Management Options for Aplastic Anemia

Array

Activity Info

This case examines the treatment approaches for aplastic anemia, including immunosuppressant therapy (IST), hematopoietic stem cell transplantation (HSCT), and supportive care. It explores appropriate patient selection based on etiology and other considerations (eg, severity of disease, patient age, etc).
Email

Search